Johns Hopkins University School of Medicine
Baltimore, United States
Dr. Stuart Grossman is Professor of Oncology, Medicine, and Neurosurgery at the Johns Hopkins University School of Medicine. He attended Harvard College and the University of Rochester Medical School before specializing in internal medicine (University of Rochester) and medical oncology (Johns Hopkins University). In 1981, he joined the faculty at Johns Hopkins to build its brain tumor program. Dr. Grossman has extensive experience in directing large, complex, NIH funded, multi-site, multidisciplinary, translational and early phase clinical brain cancer studies. He has received continuous funding as a Program Leader by the NCI for the past 35 years. He has been Principal Investigator and Director of the Central Operations Office of the NCI funded New Approaches to Brain Tumor Therapy (NABTT) and Adult Brain Tumor Consortium (ABTC) since 1994 and has also served as President of the Society for Neuro-Oncology, Chairman of ECOG’s Brain Tumor Working Group, and Chairman of NCCN Committees to develop patient care algorithms for patients with brain tumors and cancer pain. In addition, Dr. Grossman has been continually involved in training and mentoring fellows and junior faculty. For 25 years he served as Principal Investigator of the NIH funded T32 fellowship grant titled “Research Training in Neuro-Oncology” and is the recipient of teaching and mentoring awards. He has directed phase I, II, and III brain cancer trials and has published extensively on topics related to neuro-oncology. In addition, Dr. Grossman continues to pursue his own brain tumor research interests which currently include: 1) novel methods to transiently disrupt the blood brain barrier to increase the delivery of systemically administered chemotherapy to the brain and 2) new approaches to reduce the severity of treatment-related lymphopenia which is common in patients with brain tumors and associated with early death and poor response to immunotherapy treatments.